Clinical Trials Browser

Phase 1 × Hyperinsulinism × Clear all

NCT05989347 2025-03-19

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy

Phase 1 Recruiting

Breast Neoplasms, Hyperinsulinism

NCT02021604 2024-07-16

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Phase 1 Recruiting

Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism